Stakeholders Push Drug Shortage Mitigation Plans As FDA Crafts Protocol

As FDA establishes a protocol for how the agency will handle drug shortage notifications, the International Society for Pharmaceutical Engineering (ISPE) is pushing initiatives to better address shortage situations, such as building business continuity plans and internally tracking the quality of products. Other stakeholders are floating approaches under which FDA would provide incentives to companies that develop products where shortages exist, such as promising to buy the rest of the product if it isn't sold to healthcare providers, while others...